510(k) Report

FDA applicant

Avertix Medical, Inc.

Eatontown1 decision2018–20181 recall

FDA records 1 decision for Avertix Medical, Inc. (Eatontown) in 2018: 1 original PMA approval. All are in product code QBI (Acute Coronary Syndrome Event Detector). 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Avertix Medical, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2018

2018: 1
2018high 1 (2018) · low 0 (2019)2026

2026 so far, outlined.

Recalls per year

1in 2023

2023: 1
2018high 1 (2023) · low 0 (2018)2026

Class I Class II/III not classified

FIG. 1 — Avertix Medical, Inc. by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Avertix Medical, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report